AbbVie Rallies Alongside Q4 Beats
Roper Technologies delivered strong fourth-quarter results exceeding market expectations, yet concerns linger about long-term ...
AbbVie reported strong Q4 results, driven by Skyrizi, Rinvoq, neuroscience products, and eye care. Click here to find out why ...
Exxon Mobil reported Q4 results with revenues of $83.4B, missing expectations. Adjusted EPS beat at $1.67 & company plans to ...
Nokia's earnings exceeded expectations despite a slight revenue miss.
AbbVie's strong earnings and growth projections make it a solid buy for 2025, with no major patent expirations until 2030. Learn more on ABBV stock here.
Reports Q4 revenue $13.2B vs. $11.4B last year. Vas Narasimhan, CEO of Novartis (NVS), said: “In our first full year as a pure-play innovative ...
AbbVie Q4 earnings beat estimates, driven by strong sales of Skyrizi and Rinvoq, with an updated 2027 combined revenue ...
As one of the foremost electric vehicle companies in the world, Tesla continues to be an important company to watch in tech, ...
Reports Q4 revenue $3.7B, consensus $3.97B. Tim Knavish, PPG (PPG) chairman and chief executive officer, commented on the year and quarter: ...
Northrop Grumman Corp (NYSE:NOC) reported fourth-quarter sales that were flat year over year at $10.686 billion, missing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback